Pump delivery of hormone may steady calcium levels in rare disorder
NCT ID NCT00743782
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested two ways of delivering synthetic parathyroid hormone (PTH) to people with chronic hypoparathyroidism, a condition where the body doesn't make enough PTH, causing low calcium. Researchers compared using an insulin pump to give steady, small doses versus twice-daily injections. The goal was to see if the pump could keep blood and urine calcium levels more stable, mimicking natural hormone release. The trial included 21 adults and children with different forms of the disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- synthetic human parathyroid hormone (PTH 1-34)
- What this could lead to
- If successful, this could offer a more convenient and effective way to manage hypoparathyroidism, reducing daily fluctuations in calcium levels.
- What could go wrong
- This is a small, early-phase study with only 21 participants, so results may not apply to everyone. The pump method may not work better or could have side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTOIMMUNE POLYENDOCRINE SYNDROME TYPE 1 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, 20892, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A bowl of oats a day: could it boost calcium in pregnancy?
- Could a daily shot free teens from calcium pills?
- Weekly shot could free hypoparathyroidism patients from daily pills
- New daily shot could ease rare hormone disorder
- Glowing goggles could prevent calcium crash after thyroid surgery
- MRNA therapy offers hope for rare hormone disorder